Target intelligence / Profile preview

O-polysaccharide of Salmonella enterica serovar Enteritidis (O-Ag (for O-antigen), OPS (for O-polysaccharide))

Target
O-Ag (for O-antigen), OPS (for O-polysaccharide)
Molecular classification
Polysaccharide, Surface antigen, Bacterial cell wall component, Group IV capsule (in capsule form), Other
01

Overview

The O-polysaccharide of Salmonella enterica serovar Enteritidis, also known as the O-antigen, is a repetitive glycan polymer that constitutes the outermost domain of the LPS molecule on the bacterial surface. It is composed of repeating units of sugars—mannose, rhamnose, galactose, and tyvelose (the latter conferring the O:9 serotype specificity)[2][6]. This structure serves as a major antigenic determinant for the classification of Salmonella serovars and acts as both a virulence factor and a protective antigen. The O-antigen allows the bacterium to evade immune detection and contributes to resistance against complement-mediated lysis and phagocytosis. It is the principal target for vaccine strategies aiming to prevent Salmonella enterica infections, including conjugate vaccines that elicit protective antibody responses[2][6]. The O-antigen capsule, a structure highly similar to the LPS O-polysaccharide, also plays a role in environmental persistence and transmission[3][4]. There are no direct small-molecule inhibitors of O-polysaccharide, making anti-OPS immunity an indirect but critical therapeutic and preventive strategy.

Other names
O-antigen of S. EnteritidisO-specific polysaccharide (OSP)O-Ag (O-antigen)Group D1 O-antigenSalmonella Enteritidis O-polysaccharide
02

Mechanism of action

Induction of O-antigen–specific protective antibodies leading to opsonophagocytosis, complement-mediated killing, and protective immunity

03

Biological functions

Immune evasion (shields against complement and phagocytosis)Serotype determinationVirulence factorEnvironmental persistence (as O-Ag capsule)Host–pathogen interaction
04

Disease associations

Infection (contributes to pathogenesis of Salmonella enterica infections, including gastroenteritis and systemic salmonellosis)Other (important in chronic carriage and shedding)
05

Safety considerations

Potential for antigenic variability (may reduce cross-protection of vaccines)Risk of production-related reactogenicity for polysaccharide-based vaccines (as with many bacterial polysaccharides)Minimal direct toxicity as a target itself; safety concerns relate more to vaccine development than targeting the OPS directly
06

Interacting drugs

O-antigen conjugate vaccines (e.g., experimental conjugate vaccines using O-polysaccharide/protein conjugates)

1 more in the full profile.

07

Biomarkers

O-antigen–specific antibody titers (used for monitoring vaccine responses or previous exposure)

Beyond the preview

Go deeper on O-polysaccharide of Salmonella enterica serovar Enteritidis (O-Ag (for O-antigen), OPS (for O-polysaccharide)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on O-polysaccharide of Salmonella enterica serovar Enteritidis (O-Ag (for O-antigen), OPS (for O-polysaccharide)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call